Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules (Finanzen.net)
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food and Drug Administration (FDA) has issued a tentative approval letter related to the New Drug Application (NDA) for Stavzor (valproic acid delayed release ...
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules (wallstreet:online AG)
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food and Drug Administration
pSivida Receives NASDAQ Notification Related to Minimum Bid Price (Finanzen.net)
pSivida Limited (NASDAQ: PSDV)(ASX: PSD)(FF: PSI), a global drug delivery company, today announced that on December 27, 2007, the Company received a letter from the NASDAQ Listing Qualifications Department notifying the Company that, ...